CoSara Diagnostics, a Joint Venture (JV) of a subsidiary of Ambalal Sarabhai Enterprises and Co-Diagnostics, Inc, Salt Lake City, Utah, USA got permission to manufacture COVID-19 test with two target genes (RdRP & E) from CDSCO. Like one gene test, this test is also highly specific and sensitive with fast and accurate diagnosis of COVID-19 infection with precise accuracy. This is one more step towards commitment of providing diagnostic kits helpful in early diagnosis, evaluation and management of treatment.
Ambalal Sarabhai Enterprises is engaged in manufacturing and marketing of pharmaceutical products, bulk drugs, industrial chemicals, detergents, toiletries, electronics, engineering products, paper, glass and plastic containers and packaging materials.
